Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Kamaz increased production of K5 trucks by 1.5 times

8/7/24 KMAZ

Delimobile launches platform for selling cars from its fleet

8/7/24 DELI

DFA-platforms have agreed to integration with Moscow Exchange

8/7/24 MOEX

APRI placed 79% of the IPO volume

8/6/24 APRI

SPB Exchange extends trading hours

8/6/24 SPBE

Sber launched an interbank pool of foreign currency liquidity

8/6/24 SBER

Moscow Exchange to suspend trading in Novabev Group shares

8/6/24 BELU

Sovcombank started creating its own NPF

8/6/24 SVCB

Rusagro starts supplying pork to China

8/5/24 AGRO

Bank of Russia registered Novabev Group's additional share issue

8/5/24 BELU